Ascendis Pharma A (ASND) Other Working Capital Changes (2019 - 2026)

Ascendis Pharma A (ASND) has 8 years of Other Working Capital Changes data on file, last reported at $7.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 2697.05% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at $95.5 million (up 60.73% YoY), and the FY2025 full-year result was $90.3 million, up 34.65% from the prior year.
• Other Working Capital Changes retreated to $7.6 million in Q1 2026, from $34.1 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $7.1 million in Q3 2023 to a low of -$10.9 million in Q1 2023.
• A 5-year average of -$1.1 million and a median of -$2.8 million in 2023 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes surged 3826.88% in 2024 and slumped 691.06% in 2025, its largest moves.
• Tracing ASND's Other Working Capital Changes over 5 years: stood at $10.9 million in 2022, then increased by 28.78% to $14.1 million in 2023, then plunged by 160.59% to -$8.5 million in 2024, then soared by 499.57% to $34.1 million in 2025, then sank by 77.57% to $7.6 million in 2026.
• Business Quant data shows ASND's Other Working Capital Changes at $7.6 million in Q1 2026, $34.1 million in Q4 2025, and -$20.2 million in Q3 2025.